Health Emergency Preparedness and Response (HERA) call launched under EU4Health
Scope: this call for tenders aims to generate scientific evidence on the immune response to the MVA-BN vaccine, focusing on the need and optimal timing of booster doses through Phase II and/or III clinical trials, comparing intradermal and subcutaneous administration, to inform public health strategies, EU policies, and stockpiling initiatives.
This is an open procedure with a maximum contract duration of 36 months.
Deadline: 21 April 2025
Hera invites to visit their website, and expresses their need of experts and rapporteurs for upcoming evaluations. Belgian contactpoint of EU4Health, based in FPS Public Health: laurence.ballieux@health.fgov.be
More information on the EU Funding & Tender Portal.
